Effects of anti-B7 monoclonal antibodies on humoral immune responses

Journal of Autoimmunity

Volumn 12, Issue 2, 1999, Pages 101-108

  Daikh, David I ^a   Wofsy, David ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Cellular activation; Costimulatory molecules; In vivo animal models; T lymphocytes

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; HUMORAL IMMUNITY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033104777     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0258     Document Type: Article

References (27)

1. Finck B., Linsley P.S., Wofsy D. 1994. Treatment of murine lupus with CTLA4Ig. Science 265: 1225-1227
2. Lenschow D., Herold K.C., Rhee L., Patel B., Koons A., Qin H-Y., Fuchs E., Singh B., Thompson C.B., Bluestone J.A. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293
3. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80: 707-718
4. Mueller D.L., Jenkins M., Schwartz R.H. 1989. Clonal expansion versus functional clonal inactivation: A costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480
5. Ledbetter J.A., Imboden J.B., Schieven G.L., Grosmaire L.S., Rabinovitch P.S., Lindsten T., Thompson C.B., June C.H. 1990. CD28 ligation in T cell activation: Evidence for two signal transduction pathways. Blood 75: 1531-1539
6. Gimmi C.D., Freeman G.J., Gribben G.J., Sugita K., Freedman A.S., Morimoto C., Nadler L.M. 1991. B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88: 6575-6579
7. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle K., Ledbetter J.A. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J. Exp. Med. 173: 721-730
8. Norton S.D., Zuckerman L., Uyrdahl K.B., Shefner R., Miller J., and Jenkins M.K. 1992. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J. Immunol. 149: 1556-1561
9. Harding F.A., McArthur J.G., Gross J.A., Raulet D.H., Allison J.P. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356: 607-609
10. Weiss A., Imboden J., Hardy K., Manger B., Terhorst C., Stobo J. 1986. The role of the T3/antigen receptor complex in T cell activation. Annu. Rev. Immunol. 6: 593-619
11. Tan P., Anasetti C., Hansen J.A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J.A., Linsley P.S. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177: 165-173
12. Milich D.R., Linsley P.S., Hughes J.L., Jones J.E. 1994. Soluble CTLA4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. J. Immunol. 153: 429-435
13. Lenschow D.J., Zeng Y., Thistlethwaite J.R., Montag A., Brady W., Gibson M.G., Linsley P.S., Bluestone J.A. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257: 789-792
14. Turka L., Linsley P.S., Lin H., Brady W., Leiden J., Wei R., Gibson M.L., Zheng X.G., Myrdal S., Gordon D., Bailey T., Boiling S.F., Thompson C.B. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89: 11102-11105
15. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Hathcock K.S., Laszlo G., McKnight A.J., Kim J., Du L., Lombard D.B., Gray G.S., Nadler L.M., Sharpe A.H. 1993. Uncovering of functional alternative CTLA4 counter-receptor in B7-deficient deficient mice. Science 262: 907-909
16. Freeman G., Borriello F., Hodes R., Reiser H., Gribben J., Ng J. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates cell proliferation and interleukin 2 production. J. Exp. Med. 178: 2185-2192
17. Gutstein N.L., Seaman W.E., Scott J.H., Wofsy D. 1986. Induction of immune tolerance by administration of monoclonal antibody to L3T4. J. Immunol. 137: 1127-1132
18. Bretscher P., Cohn M. 1970. A theory of self-nonself discrimination. Science 169: 1042-1049
19. Parker D.C., Eynon EE. 1991. Antigen presentation in aquired immunologic tolerance. FASEB J. 5: 2777
20. Finkelman F.D., Lees A., Birnbaum R., Cause W.C., Morris S.C. 1996. Dendritic cells can present antigen in vivo in a toleragenic or immunogenic fashion. J. Immunol. 157: 1406
21. Mitchison N.A., 1964. Induction of immunological paralysis in two zones of dosage. Proc. R. Soc. Lond. B Biol. Sci. 161: 275
22. Linsley P.S., Wallace P.M., Johnson J., Gibson M.G., Greene J.L., Ledbetter J.A., Singh C., Tepper M.A. 1992. Immunosuppression in vivo by a soluble form of the CTLA4 T cell activation molecule. Science 257: 792
23. Linsley P.S., Brady W., Urnes M., Gorsmaire L., Damle N.K., Ledbetter J.A. 1991. CTLA4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569
24. Staples P.J., Talal N. 1969. Relative inability to induce tolerance in adult NZB and NZB/NZW F1 mice. J. Exp. Med. 129: 123-139
25. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapse of murine EAE. Immunity 3: 739-745
26. Nakajima A., Azuma M., Kodera S., Nuriya S., Terashi A., Abe M., Hirose S., Shirai T., Yagita H., Okamura K. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur. J. Immuno. 25: 3060-3069
27. Hathcock K.S., Laszlo G., Dickler H.B., Bradshaw J., Linsley P.S., Hodes R.J. 1993. Identification of an alternative CTLA4 ligand costimulatory for T cell activation. Science 262: 905-907